ClinicalTrials.Veeva

Menu

Laser-Mediated Photodynamic Therapy of Acne Vulgaris and Rosacea

B

Bispebjerg Hospital

Status

Completed

Conditions

Acne Vulgaris and Rosacea

Treatments

Device: Long-pulsed dye laser (Candela) and PDT (methylaminolevulinate)
Device: Long-pulsed dye laser assisted fotodynamic therapy (methylaminolevulinate)
Device: Long-pulsed dye laser

Study type

Interventional

Funder types

Other

Identifiers

NCT00483145
KF-01-328309

Details and patient eligibility

About

To evaluate efficacy and adverse effect from long-pulsed dye laser versus long-pulsed dye laser-mediated photodynamic therapy for acne vulgaris and rosacea.

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Inflammatory acne and rosacea
  • Skin types I-IV

Exclusion criteria

  • Patients younger than 18 years
  • Skin types V and VI
  • Topical and systemic conventional acne treatments

Trial design

0 participants in 2 patient groups

1
Active Comparator group
Description:
Long-pulsed dye laser (Candela)
Treatment:
Device: Long-pulsed dye laser (Candela) and PDT (methylaminolevulinate)
Device: Long-pulsed dye laser
2
Active Comparator group
Description:
Long-pulsed dye laser assisted fotodynamic therapy (methylaminolevulinate)
Treatment:
Device: Long-pulsed dye laser assisted fotodynamic therapy (methylaminolevulinate)
Device: Long-pulsed dye laser (Candela) and PDT (methylaminolevulinate)

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems